News
$Scienture Holdings (SCNX.US)$ Scienture, LLC, a wholly owned subsidiary of Scienture Holdings, Inc. (NASDAQ: SCNX) Announces Issuance of a New Patent Covering its first product SCN-102 (Losartan Potassium Oral Suspension, 10mg/mL) through 20413 MINUTES AGO, 8:05 AM ESTVIA GLOBENEWSWIRE
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more